Paper447033
Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis.
Neal EA and 3 others. Gastroenterology, 1979. Cited by 119 papers, by iCite.
Cite this record
ConductScience Library. Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis. Papers, record 447033. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/447033
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver | Major topic |
| Liver Cirrhosis | Major topic |
| Meperidine | Major topic |
| Pentazocine | Major topic |
| Salicylamides | Major topic |
| Adult | |
| Biological Availability | |
| Half-Life | |
| Humans | |
| Liver Circulation | |
| Liver Function Tests | |
| Middle Aged |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38399287 | Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38399287 | PubMed |
| 27939376 | The Promises of Quantitative Proteomics in Precision Medicine. | J Pharm Sci | 2017 | https://conductscience.org/library/papers/27939376 | PubMed |
| 22867045 | Analgesics in patients with hepatic impairment: pharmacology and clinical implications. | Drugs | 2012 | https://conductscience.org/library/papers/22867045 | PubMed |
| 22346246 | Update of endoscopy in liver disease: more than just treating varices. | World J Gastroenterol | 2012 | https://conductscience.org/library/papers/22346246 | PubMed |
| 18762933 | Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. | Eur J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/18762933 | PubMed |
| 15924505 | Dose adjustment in patients with liver disease. | Drug Saf | 2005 | https://conductscience.org/library/papers/15924505 | PubMed |
| 10451781 | Pharmacokinetics of opioids in liver disease. | Clin Pharmacokinet | 1999 | https://conductscience.org/library/papers/10451781 | PubMed |
| 9820880 | Effect of hepatic insufficiency on pharmacokinetics and drug dosing. | Pharm World Sci | 1998 | https://conductscience.org/library/papers/9820880 | PubMed |
| 9638390 | Pain treatment in multimorbid patients, the older population and other high-risk groups. The clinical challenge of reducing toxicity. | Drug Saf | 1998 | https://conductscience.org/library/papers/9638390 | PubMed |
| 9258630 | Drug administration in chronic liver disease. | Drug Saf | 1997 | https://conductscience.org/library/papers/9258630 | PubMed |
| 8261714 | Individual variation in first-pass metabolism. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8261714 | PubMed |
| 7333059 | Pharmacokinetics of metoprolol in patients with hepatic cirrhosis. | Clin Pharmacokinet | 1981 | https://conductscience.org/library/papers/7333059 | PubMed |
| 7248141 | Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7248141 | PubMed |
| 7213505 | Pethidine clearance during continuous intravenous infusions in postoperative patients. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7213505 | PubMed |
| 7094988 | Comparative disposition of pethidine and norpethidine in old and young patients. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7094988 | PubMed |
| 6861871 | Steady-state kinetics and analgesic effect of oral morphine in cancer patients. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6861871 | PubMed |
| 6754208 | Clinical pharmacokinetics of pethidine: 1982. | Clin Pharmacokinet | 1982 | https://conductscience.org/library/papers/6754208 | PubMed |
| 6626417 | Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6626417 | PubMed |
| 6362950 | First-pass elimination. Basic concepts and clinical consequences. | Clin Pharmacokinet | 1984 | https://conductscience.org/library/papers/6362950 | PubMed |
| 6352139 | Clinical pharmacokinetics of narcotic agonist-antagonist drugs. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6352139 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/447033
GET https://conductscience.org/api/papers/v1/447033/cited_by?page=2